{"id":"https://genegraph.clinicalgenome.org/r/2888c8be-30c0-4bb2-ac1d-616310392ab1v1.0","type":"EvidenceStrengthAssertion","dc:description":"FGFR3 has been repeatedly described in association with autosomal dominant Thanatophoric Dysplasia Type I, which is characterized by lethal micromelic short limb dysplasia, short ribs, curved and short femurs, with cloverleaf skull in some cases (Rousseau et al. 1995; PMID: 7647778). Cysteine substitutions and stop gain variants in this gene are highly specific to TD1, and are highly causative, and for this reason they are scored at a higher level in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is also supported by experimental evidence including assays showing increased binding activity of variant FGFR3 receptor protein (PMIDs: 9438390, 8640234, 14751560). In summary, FGFR3 is definitively associated with autosomal dominant Thanatophoric Dysplasia Type I. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders Gene Curation Expert Panel on 12/6/2021. \nGene Clinical Validity Standard Operating Procedures (SOP) â€“ Version 8.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2888c8be-30c0-4bb2-ac1d-616310392ab1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/db0459d9-c5cc-455d-a6b2-e6ea81511336","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/db0459d9-c5cc-455d-a6b2-e6ea81511336_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2021-12-23T22:19:01.367Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/db0459d9-c5cc-455d-a6b2-e6ea81511336_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2021-12-23T22:18:50.458Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db0459d9-c5cc-455d-a6b2-e6ea81511336_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db0459d9-c5cc-455d-a6b2-e6ea81511336_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6325cb4d-541b-45fb-bbee-f5d137a1ebe4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b5cd774-cf5f-426d-b6e4-7c1934c4c354","type":"FunctionalAlteration","dc:description":"NIH3T3 transfected with Arg248Cys, Ser249Cys, Tyr373Cys had strongly increased receptor glycosylation, and strongly increase Stat1 and Stat5 protein expression.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14751560","rdfs:label":"Legeai-Mallet Assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dfc67e85-3595-45e2-8ce9-cc2e0568bc8d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f43885d-57c0-4f7d-a216-fc4740bbf9d9","type":"FunctionalAlteration","dc:description":"R248C and S249C showed approximately 4-fold increase in luciferase activity compared to wild-type. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9438390","rdfs:label":"d'Avis Assay 1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/156d7fb4-5005-4058-b48e-804ce350ad97","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83b65e5e-bd88-41c2-8273-0e14e7189f90","type":"FunctionalAlteration","dc:description":"After FGF1 stimulation, Arg248Cys variant receptor showed 4.5 fold increase in activation compared to WT. Transfected NIH3T3 cells showed constitutive activation of the variant receptor. Transfected COS cells showed that Arg248Cys produces a reducible dimer, WT does not. Arg248Cys leads to dimerization in presence and absence of ligand.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8640234","rdfs:label":"Naski Assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ca3006bc-6bcf-4299-abd7-6bcab8252794","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98d48884-85ec-4c07-be4b-c3f16713a24e","type":"FunctionalAlteration","dc:description":"Control variant R248A showing that the Cys substitution is responsible for activation. GOF mechanism is shown, resulting in enhanced signaling due to constitutive activation of the receptor. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9438390","rdfs:label":"d'Avis Assay 2"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/db0459d9-c5cc-455d-a6b2-e6ea81511336_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da98f9bf-a6ae-4a27-b795-3ba826b94252","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da98f9bf-a6ae-4a27-b795-3ba826b94252_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c221529-eba5-4c64-a7cb-8e579017846a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.1111A>T (p.Ser371Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341399"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1b69342e-be31-4f24-b8aa-810401841c5e","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b69342e-be31-4f24-b8aa-810401841c5e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7647778","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8a6cfb4-6411-4707-909d-17fcab747862","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.2419T>G (p.Ter807Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341401"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/826c253f-62d1-4ed1-a612-ab56ddc13e51","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/826c253f-62d1-4ed1-a612-ab56ddc13e51_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8845844","allele":{"id":"https://genegraph.clinicalgenome.org/r/665fef35-a4d8-4f40-b965-844c9c97d55b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.2419T>A (p.Ter807Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341404"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/553ff7d0-cf5e-4a67-83c6-fb8588667b8a","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/553ff7d0-cf5e-4a67-83c6-fb8588667b8a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8845844","allele":{"id":"https://genegraph.clinicalgenome.org/r/a906278a-2d5f-4b75-a4fb-76211c6ba01a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.1118A>G (p.Tyr373Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341413"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5d5e4572-ab3e-4f40-9c8d-84269ad232ee","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d5e4572-ab3e-4f40-9c8d-84269ad232ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7647778","allele":{"id":"https://genegraph.clinicalgenome.org/r/665fef35-a4d8-4f40-b965-844c9c97d55b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8c534d09-50df-4c63-b4f6-ddd7d5ad477f","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c534d09-50df-4c63-b4f6-ddd7d5ad477f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8845844","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f9e6851-2251-4fed-a939-d19404575b12","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.746C>G (p.Ser249Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA126380"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3836c170-6ee0-46b9-aff1-5e3a798dd8d0","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3836c170-6ee0-46b9-aff1-5e3a798dd8d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.742C>T (p.Arg248Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA126378"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/53b9666c-c491-4a4e-a49a-88341f4f52ef","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53b9666c-c491-4a4e-a49a-88341f4f52ef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2bf0ca8a-b3c8-4e3d-b651-694fe278633e","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bf0ca8a-b3c8-4e3d-b651-694fe278633e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8845844","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9da3da03-c24a-46d9-bda8-299aaead90fb","type":"EvidenceLine","dc:description":"Radiographs providing phenotypic specificity in this case.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9da3da03-c24a-46d9-bda8-299aaead90fb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional study in zebrafish showing overexpression of FGFR3 and overactivation of downstream signalling.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9da3da03-c24a-46d9-bda8-299aaead90fb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27028100","allele":{"id":"https://genegraph.clinicalgenome.org/r/c901de8b-a35a-413a-ac0d-de53cf0e9bba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.742_743insTGT (p.Arg248delinsLeuCys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2541708611"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3e6b4d48-590e-4cfa-bfaf-7b707c0b7462","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e6b4d48-590e-4cfa-bfaf-7b707c0b7462_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7647778","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7533bf5-ffc2-4dd3-8a21-c80faeb44b6a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.2421A>T (p.Ter807Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341407"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e7dca542-25a2-4bae-bdc4-ed5758dcdbae","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7dca542-25a2-4bae-bdc4-ed5758dcdbae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4519fff1-2e24-4564-a00b-734df532eb7f","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4519fff1-2e24-4564-a00b-734df532eb7f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d93c9580-6305-4ea0-a392-efc852fe61d4","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d93c9580-6305-4ea0-a392-efc852fe61d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8845844","allele":{"id":"https://genegraph.clinicalgenome.org/r/d6e5ef0d-f4d2-456c-a600-56fc8cc50dcc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.1108G>T (p.Gly370Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129946"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1c82d922-817b-4765-bdb8-9d76b40c17eb","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c82d922-817b-4765-bdb8-9d76b40c17eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8845844","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7533bf5-ffc2-4dd3-8a21-c80faeb44b6a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":3823,"specifiedBy":"GeneValidityCriteria8","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/xXRM1QfzNbc","type":"GeneValidityProposition","disease":"obo:MONDO_0008546","gene":"hgnc:3690","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_db0459d9-c5cc-455d-a6b2-e6ea81511336-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}